🔎 Trials Near Me

Home › Multiple Myeloma › Texas › San Antonio

Multiple Myeloma clinical trials in San Antonio, TX

6 studies for Multiple Myeloma are looking for participants at sites in and around San Antonio (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

RecruitingPhase 3
  • Texas Transplant Institute, San Antonio
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07258511

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

RecruitingPhase 2
  • Methodist HealthCare System of San Antonio Clinical Trials Office, Texas Transplant Institute, San Antonio
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT06297226

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

RecruitingPhase 2
  • START San Antonio, San Antonio
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT07284758

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

RecruitingPhase 3
  • University of Texas Health Science Center at San Antonio, San Antonio
All ages · All sexes · Updated Jun 10, 2026 · NCT05561387

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

RecruitingPhase 2
  • Texas Oncology - San Antonio, San Antonio
Ages 18 and older · All sexes · Updated Apr 22, 2026 · NCT05972135

About Multiple Myeloma

Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.

More about Multiple Myeloma on MedlinePlus

Multiple Myeloma trials in other cities

Other studies in San Antonio

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.